Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Dr Oswaldo Aguilar, Universidad del Valle, Colombia

Dr. Oswaldo Aguilar 🩺❤️ is a cardiologist and echocardiography specialist at Hospital Universitario del Valle, Colombia. He also serves as a lecturer at Universidad del Valle and Universidad Libre. Dr. Aguilar holds a medical degree from Universidad Rafael Núñez and specialized in Internal Medicine and Clinical Cardiology. A prolific author, he has contributed to key medical textbooks and journals 📚. He is a member of the American College of Physicians, the Sociedad Colombiana de Cardiología, and ESC. Passionate about cardiovascular imaging and heart failure research, Dr. Aguilar actively shapes future medical professionals through teaching and mentorship. 🎓💉

Publication Profile

Scopus

Clinical Expertise and Teaching

Dr. Oswaldo Aguilar is a dedicated cardiologist and medical educator 🩺❤️. Since January 2024, he has worked at Hospital Universitario del Valle in advanced cardiac imaging. He also teaches postgraduate internal medicine and cardiology at Universidad del Valle and Universidad Libre, Cali 👨‍🏫. Dr. Aguilar has been a cardiologist at Colsanitas S.A. since 2022. Previously, he completed a cardiology fellowship at Universidad de Antioquia and practiced internal medicine at Hospital Universitario del Valle and Fundación Valle de Lili 🏥. His experience spans urgent care, hospital wards, and intensive care, showcasing his commitment to patient care and medical training.

Complementaria

Dr. Oswaldo Aguilar is a dedicated cardiologist with advanced training in cardiovascular imaging and clinical care ❤️‍🩹. He completed an ultrasound program for major syndromes at Universidad Cardenal Herrera (2019-2020) and holds diplomas in cardiovascular medicine 🫀 and clinical research 📊. His expertise spans heart failure management, anticoagulation, and pulmonary hypertension. He has extensive hands-on training, including a 2024 rotation in advanced cardiac imaging at Hospital Clínico San Carlos, Madrid 🏥. Certified in ACLS and trauma care, Dr. Aguilar is a Fellow in Training with the ACC (2020-2023) and proficient in POCUS imaging techniques 📈.

Recognition and Affiliations

Dr. Oswaldo Aguilar is a distinguished cardiologist with memberships in prestigious organizations, including the American College of Physicians 🩺, Sociedad Colombiana de Cardiología ❤️, and the European Society of Cardiology (ESC) 🌍. His affiliations reflect his dedication to advancing cardiovascular medicine and active participation in global cardiology networks. Dr. Aguilar’s involvement in these esteemed societies highlights his commitment to staying at the forefront of medical research and innovation, fostering collaboration with experts worldwide. Through these connections, he continually enhances his expertise, contributing to improved patient care and shaping the future of cardiology.

Research Focus

Dr. Oswaldo Aguilar’s research focuses on cardiovascular health 🫀, particularly in echocardiographic findings, aortic stenosis, heart failure, and coronary artery disease. His studies analyze systemic lupus erythematosus patients, mortality predictors, and atrial fibrillation treatments. Dr. Aguilar’s work spans retrospective cohort studies and practical reviews, emphasizing real-world applications in cardiology clinics and emergency rooms 🏥. His publications address critical issues like prosthetic valve thrombosis, aiming to improve patient outcomes through advanced diagnostic and therapeutic strategies. Dr. Aguilar’s contributions reflect a dedication to enhancing cardiovascular care and advancing knowledge in cardiology 📚❤️.

Publication Top Notes

Echocardiographic findings in patients with systemic lupus erythematosus: Retrospective analysis in a tertiary referral centre | Hallazgos ecocardiográficos en pacientes con lupus eritematoso sistémico: análisis retrospectivo en un centro de referencia terciaria

Low-Flow, Low-Gradient Severe Aortic Stenosis in patients with preserved or reduced ejection fraction: a systematic literature review.

Application of eligibility criteria from DAPA-HF, EMPEROR-Reduced, and PARADIGM-HF trials to a population with heart failure with reduced ejection fraction at a specialized cardiology Clinic in Medellin, Colombia: A retrospective cohort study

Atrial fibrillation treatment in the emergency room: a practical narrative review | Tratamiento de la fibrilación auricular en el servicio de urgencias: una revisión práctica de la literatura

Predictors of mortality in patients with coronary artery disease and involvement of the left main artery | Factores predictores de mortalidad en pacientes con enfermedad coronaria y compromiso del tronco principal izquierdo

Prosthetic valve thrombosis and thrombolytic therapy in the modern era: a case report | Trombosis valvular y terapia trombolítica en la era moderna: reporte de un caso

 

Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Prof. Luis Sobrevia, Pontificia Universidad Católica de Chile, Chile

Prof. Luis Sobrevia is a distinguished Chilean physiologist with extensive academic and research credentials. He completed his BSc in Biological Sciences from Universidad del Bío-Bío, MSc in Physiological Sciences from Universidad de Concepción, and PhD in Physiology and Biomedicine from King’s College London. He has held postdoctoral training at King’s College London and earned a Diploma in University Teaching from Pontificia Universidad Católica de Chile (PUC). As a Fellow of The Physiological Society (UK) and the International Union of Physiological Sciences, he holds prominent academic positions worldwide, including at PUC, TecSalud in Mexico, and UNESP in Brazil. His research focuses on placental vascular dysfunction in pregnancy complications like gestational diabetes and obesity, studying pathways that affect maternal-fetal health. He has mentored numerous PhD and MSc students and collaborates globally on groundbreaking research. 🌍🔬

Publication Profile

Education

Prof. Luis Sobrevia holds a BSc Hons. in Biological Sciences (1986) from Universidad del Bío-Bío, Chile, and an MSc in Physiology (1990) from Universidad de Concepción, Chile. He earned his PhD in Physiology and Biomedicine (1996) at King’s College London, UK, followed by a postdoctoral fellowship there. Prof. Sobrevia has held academic positions globally, currently serving as a Distinguished Research Professor at Tecnológico de Monterrey, Mexico, and as an Honorary Professor in Australia, Spain, and Brazil. His extensive experience spans physiology, biomedicine, and university teaching, making significant contributions to obstetrics and biomedical sciences. 🏥📚

 

Research

Prof. Luis Sobrevia leads an extensive research group comprising PhD students from various global institutions, such as PUC Chile, U Talca, UNESP Brazil, and U Coimbra, Portugal. His team includes MSc and undergraduate students, along with technical research assistants like biochemist K Silva. The group hosts postdoctoral researchers, including A Grismaldo and MA Pascon. Collaborations span prestigious institutions like University Medical Centre Groningen, TecSalud, and Karolinska Institutet. As a thesis supervisor, Prof. Sobrevia has mentored 69 students across PhD, MSc, and undergraduate levels, focusing on physiology, biomedicine, and molecular biology. 🌍📚💡

 

Teaching Experience 🎓📚

Prof. Luis Sobrevia is a dedicated educator, teaching undergraduate courses in Medicine, Biology, Biochemistry, Nutrition, and Bioethics. He also mentors postgraduate students, including PhD, MSc, and medical specialization programs. His teaching spans top universities in Chile (PUC, UCH, UT, UA, UACH, UDEC) and internationally at institutions like UMCG (Netherlands), US (Spain), KCL (UK), AUT (New Zealand), UQCCR (Australia), UNESP (Brazil), and TecMonterrey (Mexico). His expertise covers topics such as gestational diabetes, fetal vascular dysfunction, cardiovascular pathophysiology, endothelial physiology, and insulin and adenosine signaling. 🌍🩺📖

 

Academic and Scientific Merit Recognitions 🌟🏅

Prof. Luis Sobrevia has earned numerous prestigious awards and appointments throughout his academic career. In 2024, he was nominated as a Corresponding Member of the Chilean Academy of Sciences and recognized for his contributions to internationalization by the Mexican Society of Physiological Sciences. He was also appointed Co-president of the Regional Focal Point for Latin America and the Caribbean (RFP-LAC) of the International Science Council (ISC) and Editor-in-Chief of Physiological Minireviews. His leadership extends to roles such as Regional Editor for The Journal of Physiology and member of international scientific committees, highlighting his significant global impact. 🌍📚💡

 

Publication Top Notes

  • Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells by GE Mann, DL Yudilevich, L Sobrevia, Physiological reviews 83 (1), 183-252, Cited by: 578, 2003 📚💉
  • A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration by C Salomon, MJ Torres, M Kobayashi, K Scholz-Romero, L Sobrevia, PloS one 9 (6), e98667, Cited by: 412, 2014 🤰🔬
  • Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis by C Salomon, J Ryan, L Sobrevia, M Kobayashi, K Ashman, M Mitchell, PloS one 8 (7), e68451, Cited by: 400, 2013 🌱💧
  • Oxidative stress: Normal pregnancy versus preeclampsia by DI Chiarello, C Abad, D Rojas, F Toledo, CM Vázquez, A Mate, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (2), 165354, Cited by: 325, 2020 🩸💔
  • Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes by C Salomon, M Kobayashi, K Ashman, L Sobrevia, MD Mitchell, GE Rice, PloS one 8 (11), e79636, Cited by: 213, 2013 🌍💫
  • Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia by L Sobrevia, GE Mann, Experimental Physiology: Translation and Integration 82 (3), 423-452, Cited by: 208, 1997 🧬🩺
  • Activation of L‐arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells by L Sobrevia, A Nadal, DL Yudilevich, GE Mann, The Journal of physiology 490 (3), 775-781, Cited by: 204, 1996 ⚡💡
  • Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy by SD Calligaris, M Lecanda, F Solis, M Ezquer, J Gutierrez, E Brandan, PloS one 8 (4), e60931, Cited by: 189, 2013 🍔❤️
  • Extracellular vesicles in obesity and diabetes mellitus by F Pardo, R Villalobos-Labra, B Sobrevia, F Toledo, L Sobrevia, Molecular aspects of medicine 60, 81-91, Cited by: 187, 2018 🧬🍩
  • Early activation of the p42/p44MAPK pathway mediates adenosine‐induced nitric oxide production in human endothelial cells: a novel calcium‐insensitive … by AW Wyatt, JR Steinert, CPD Wheeler‐Jones, AJ Morgan, D Sugden, The FASEB journal 16 (12), 1584-1594, Cited by: 155, 2002 🔬💡

 

 

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award

Posted on by ScienceFather

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award 

Dr. Miguel Virseda-Chamorro, FEA, Hospital Nacional de parapléjicos, Spain.

Miguel Vírseda Chamorro is a seasoned medical professional with expertise in urology. Born in Zaragoza, Spain, in 1956, Miguel has dedicated over three decades to research, education, and clinical practice in the field of urology. Throughout his career, he has specialized in the treatment of lower urinary tract disorders, urological dysfunctions, and has made significant contributions through his research in the field of neurourology and urodynamics.

Profile

scopus

orcid

Strengths for the Award

  1. Extensive Research Background: Chamorro has participated in numerous clinical trials and published papers over decades, specifically focusing on urology and related areas such as spinal cord injuries and urinary tract infections.
  2. Recognized Expertise: His work has been acknowledged with multiple awards and recognitions, including best doctoral thesis and research prizes in the field of urology.
  3. International Contributions: Chamorro’s involvement in various international scientific meetings (e.g., International Continence Society) and peer-reviewed publications highlights his contributions to global scientific dialogue.
  4. Educational Contributions: Directing doctoral theses and contributing to advanced academic courses in urology positions him as a thought leader in his field.

Areas for Improvement

  • Interdisciplinary Reach: While his work is specialized in urology, expanding to interdisciplinary research that bridges other medical fields or innovations in treatment techniques might add depth to his paper’s impact.

Novel Research: Chamorro has done extensive work on known conditions, but for a “Best Paper Award,” research on cutting-edge topics, such as emerging technologies or new medical approaches, could further elevate his candidacy.

Education 🎓

Miguel Vírseda Chamorro has a diverse and accomplished educational background. He began his academic journey with a degree in Industrial Engineering at the Universidad Politécnica de Las Palmas in 1973. He later obtained his Licenciatura in Medicine and Surgery from the University of Valencia in 1981, followed by a degree in Law from the National University of Distance Education (UNED) in 2011. He specialized in Urology at Hospital Gómez Ulla in 1990 and pursued further studies, earning a Master’s in Design and Statistics in Health Sciences from the Autonomous University of Barcelona in 2001. His Doctoral Thesis, completed in 1992, received the prestigious Cum Laude distinction.

Experience 💼

Miguel’s career spans over three decades, including extensive experience in urological surgery, teaching, and research. He became a Fellow of the European Board of Urology in 1992 and has been an accredited Professor since 2005, working with several medical institutions. His medical experience is also enriched by his work as Director of Radiodiagnostic Installations, certified by the Spanish Nuclear Safety Council in 2007. He has served in various clinical roles, significantly contributing to both the practice and teaching of urology and urodynamics.

Research Interests 🔬

Miguel’s primary research interests lie in neurourology, urodynamics, and the impact of pelvic dysfunction on urinary systems. His research has focused on urinary tract dysfunctions, neurogenic detrusor overactivity, and the application of botulinum toxin in urological conditions. He is particularly interested in exploring diagnostic techniques, treatment methods, and prognostic factors for patients with spinal cord injuries and other neurological disorders affecting urological health.

Awards and Recognition 🏆

Miguel has been recognized with numerous awards for his outstanding work in the field of urology. In 1992, his doctoral thesis was awarded the Best Thesis Prize by the Spanish Association of Urology. He has received multiple accolades, including the Enrique Pérez Castro Third Prize for his research on urodynamic models in 1998, and the distinction for “Best Urological Functional Case” at the National Urology Congress in 2011. His latest recognition includes the ACACI Research Award for his study on chronic pelvic pain syndrome in women.

Publications 📚

Miguel has published extensively in renowned medical journals, contributing significantly to the field of urology. Below are some of his recent publications:

    1. Abdominal strength in voiding cystometry: a risk factor for recurrent urinary tract infections in women. Int Urogynecol J, 2015. Cited by: 45
    2. Risk factors of urethral diverticula in male patients with spinal cord injury. Spinal Cord, 2015. Cited by: 23
    3. Post Pelvic Radiotherapy Affectation of the Lower Urinary Tract Peripheral Innervation in Men. Urol Int, 2017. Cited by: 18
    4. Influence of bladder lithiasis on lower urinary tract dynamics in patients with spinal cord injury. Spinal Cord, 2017. Cited by: 30
    5. Clinical and urodynamic risk factors for recurrent urinary tract infections in multiple sclerosis. Multiple Sclerosis Journal, 2018. Cited by: 35

Conclusion

Chamorro’s achievements in urology and academic research, coupled with his global recognition, make him a strong contender for the award. Expanding his research focus and emphasizing innovation in his recent work would further bolster his potential for winning.

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

 

 

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Posted on by ScienceFather

Prof Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Prof Dr. Pedro Antonio Regidor, Exeltis, Germany

Born on January 5, 1964, in Madrid, Spain, Prof. Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Prof. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Prof. Dr. Pedro Antonio Regidor, born on January 5, 1964, in Madrid, Spain, and holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Prof. Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Prof. Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

  • “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
  • “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
  • “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
  • “Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
  • “Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
  • “The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
  • “Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
  • “Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅


Conclusion

Prof. Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.

 

 

 

 

 

 

 

 

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Dr Mohammadamin Parsaei, Maternal, Fetal & Neonatal Research Center, Iran

Dr. Mohammadamin Parsaei is a prominent academic and researcher specializing in [specific field]. He holds a [degree] from [institution] and has extensive experience in [area of expertise]. Dr. Parsaei is known for his contributions to [specific research focus or project], with numerous publications and impactful research outcomes. He is currently affiliated with [institution] as a [position], where he continues to advance knowledge in [field]. His work is widely recognized for its innovation and excellence. 📚🔬

Publication profile

google scholar

Education

Dr. Mohammadamin Parsaei earned their Doctor of Medicine degree from Tehran University of Medical Sciences in 2023, with a GPA of 3.68/4. Their thesis, titled “Assessing Clinical Outcomes of Adrenalectomy and Associated Factors: A Retrospective Study in Iran,” was successfully defended before the General Surgery faculty at Dr. Shariati Hospital, Tehran University of Medical Sciences. This research delves into the clinical outcomes of adrenalectomy procedures and explores the associated factors affecting patient outcomes in Iran. 🏥📚👩‍⚕️

Experience

Dr. Mohammadamin Parsaei is a Postdoctoral Research Fellow at the Maternal, Fetal & Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences (2023-present). In this role, Dr. Mohammadamin Parsaei conducts clinical trials, observational studies, and reviews in Obstetrics and Gynecology, Infertility, and Maternal-Fetal research. Responsibilities include statistical analysis, overseeing research projects, crafting proposals, and managing article submissions. Additionally, Dr. [Name] serves as a Research Supervisor at ResearchPlus Academy (2024-present) and NCWEB Association (2023-present), leading systematic reviews and meta-analyses in multidisciplinary fields and neuroradiology. 🧪📊🔬

Research focus

The research of M. Parsaei predominantly focuses on psychiatric and psychological disorders, neuroimaging, and reproductive health. Key areas include the efficacy and safety of psychiatric medications, the impact of neuroimaging on mental health conditions like schizophrenia and social anxiety disorders, and the role of various interventions in managing these conditions. Parsaei’s work also extends to evaluating treatments for reproductive health issues, such as ectopic pregnancies, and the effects of maternal obesity on offspring brain development. This diverse research contributes to understanding and improving mental health, neuroimaging techniques, and reproductive outcomes. 🧠🔬💊👶

Publication top notes

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial

Classification of suicidality by training supervised machine learning models with brain MRI findings: A systematic review

White matter alterations in affective and non-affective early psychosis: A diffusion MRI study

Methotrexate as the first-line treatment of unruptured tubular ectopic pregnancies with high initial human chorionic gonadotropin levels: A retrospective cohort

Effects of non-pharmacological interventions on gait and balance of persons with Multiple Sclerosis: A narrative review

Microstructural white matter alterations associated with social anxiety disorders: A systematic review

Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial

Machine Learning for Prediction of Violent Behaviors in Schizophrenia Spectrum Disorders: A Systematic Review

White matter correlates of impulsive behavior in healthy individuals: A diffusion MRI study

Predicting the Outcomes of In Vitro Fertilization Using Baseline Maternal Serum Inflammatory Markers: A Retrospective Cohort Study

Ziliang Zheng | Nanomedicine Award | Best Researcher Award

Posted on by ScienceFather

Prof. Ziliang Zheng | Nanomedicine Award | Best Researcher Award

Prof. Ziliang Zheng, Laboratory of Molecular Imaging, Fifth Hospital of Shanxi Medical University (Shanxi Provincial People’s Hospital, China

Prof. Ziliang Zheng 🎓 is a leading figure in molecular imaging and nano biomedicine. With a Master’s Degree, he serves as Deputy Director of the Molecular Imaging Lab at Shanxi Provincial People’s Hospital. He’s a prolific researcher, with groundbreaking work in NIR-II fluorescence imaging, resulting in 38 SCI papers and 17 patents. Prof. Zheng’s innovative systems, like the NIR-II fluorescence imaging system, have advanced surgical navigation and intraoperative pathology. An esteemed educator, he mentors doctoral and master’s students, fostering future leaders in nanomedicine. His accolades include the Shanxi Provincial Science and Technology Cooperation Award (First Prize) and the Huaxia Medical Science and Technology Award (Second Prize).

Publication Profile

Google Scholar

Research Achievements 🏆

Ziliang Zheng, a distinguished professor and master’s degree supervisor, has made remarkable contributions in the field of molecular imaging at Shanxi Provincial People’s Hospital. His pioneering work focuses on near infrared two-region (NIR-II) fluorescence imaging technology, culminating in the development of advanced NIR-II fluorescence imaging systems for surgical navigation, intraoperative pathology analysis, and endoscopic diagnosis. With 38 SCI papers and 17 patents to his name, Zheng’s research has garnered international recognition. His dedication to scientific rigor and clinical translation has earned him prestigious awards, including the Shanxi Provincial Science and Technology Cooperation Award.

Honors & Recognition 🌟

Zheng’s contributions have been honored with awards such as the Huaxia Medical Science and Technology Award and the China Anti-Cancer Association Science and Technology Award. These accolades not only celebrate his scientific achievements but also validate his unwavering commitment to improving patient care through cutting-edge research and innovation.

 

Research Focus

Zheng Z. is a prolific researcher whose work primarily focuses on developing advanced nanotheranostic platforms for cancer diagnosis and treatment. 🧪 His research spans various areas, including the design and synthesis of multifunctional nanomaterials, such as silica-based nanotheranostics and zeolite-supported catalysts, for precise imaging (MRI/NIR-II fluorescence) and therapeutic interventions (photothermal therapy, gas therapy). 🩺 Zheng Z.’s innovative approaches aim to address key challenges in tumor diagnosis and therapy, paving the way for bench-to-bedside applications with potential clinical impact. 🚀

 

Publication Top Notes